The risk factors of portal vein thrombosis in patients with liver cirrhosis

Basit Öğe Kaydı
dc.authoridYildirim, Oguzhan/0000-0001-8254-0104
dc.authoridHarputluoglu, Muhsin Murat Muhip/0000-0002-9415-147X
dc.authoridCagin, Yasir Furkan/0000-0002-2538-857X
dc.authoridBERBER, Ilhami/0000-0003-3312-8476
dc.authoriderdogan, mehmet ali/0000-0002-1713-5695
dc.authoridARSLAN, Ahmet Kadir/0000-0001-8626-9542
dc.authoridÇOLAK, CEMİL/0000-0001-5406-098X
dc.authorwosidYildirim, Oguzhan/ABI-8174-2020
dc.authorwosidHarputluoglu, Muhsin Murat Muhip/ABI-3094-2020
dc.authorwosidCagin, Yasir Furkan/ABI-2709-2020
dc.authorwosidBERBER, Ilhami/ABI-6231-2020
dc.authorwosidSeckin, Yuksel/ABI-3468-2020
dc.authorwosiderdogan, mehmet ali/ABI-4675-2020
dc.authorwosidARSLAN, Ahmet Kadir/AAA-2409-2020
dc.contributor.authorCagin, Yasir Furkan
dc.contributor.authorBilgic, Yilmaz
dc.contributor.authorBerber, Ilhami
dc.contributor.authorYildirim, Oguzhan
dc.contributor.authorErdogan, Mehmet Ali
dc.contributor.authorFirat, Feyza
dc.contributor.authorArslan, Ahmet Kadir
dc.date.accessioned2024-08-04T21:02:11Z
dc.date.available2024-08-04T21:02:11Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThis study was designed to identify and assess risk factors for portal vein thrombosis (PVT) in patients with cirrhosis. A total of 98 cirrhosis patients with PVT were identified and 101 cirrhosis patients without PVT were chosen as the control group in this retrospective study. Several variables were measured and the two groups PVT and non-PVT were compared statistically. PVT was identified in 98 patients (10%). Significant differences in hematocrit, international normalized ratio, albumin, bilirubin and glucose were determined between the groups (P<0.05). Out of the thrombophilic risk factors in the patients with PVT factor V Leiden was identified in 8.8%, prothrombin gene 6.6% and methylenetetrahydrofolate reductase 2.2%. There was no difference in survival time between groups (P>0.05).en_US
dc.identifier.doi10.3892/etm.2019.7300
dc.identifier.endpage3194en_US
dc.identifier.issn1792-0981
dc.identifier.issn1792-1015
dc.identifier.issue4en_US
dc.identifier.pmid30936992en_US
dc.identifier.startpage3189en_US
dc.identifier.urihttps://doi.org/10.3892/etm.2019.7300
dc.identifier.urihttps://hdl.handle.net/11616/104556
dc.identifier.volume17en_US
dc.identifier.wosWOS:000463793600106en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpandidos Publ Ltden_US
dc.relation.ispartofExperimental and Therapeutic Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcirrhosisen_US
dc.subjectportal vein thrombosisen_US
dc.subjectrisk factorsen_US
dc.titleThe risk factors of portal vein thrombosis in patients with liver cirrhosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu